AbSci

AbSci is the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Our goal is to enable the development of better medicines. We Translate Ideas into Drugs™. Based in Vancouver, Washington, ten minutes from Portland, Oregon, we’re located within an hour of world class alpine terrain and rugged Pacific coastlines.